Announcements Trials
Browse Landscape

Phase

Phase 1/2 30Phase 1 29Phase 2 25Phase 3 9Phase NA 6Phase 4 4Phase 2/3 3Phase EARLY_PHASE1 2

Status

Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 277Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Pain, Postoperative 43Head and Neck Neoplasms 43Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

spartalizumab 1ruxolitinib 1dolutegravir 1Rituximab 1Ritonavir 1Nucleosides 1Dexamethasone 1Darunavir 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Epstein-Barr Virus Infections × Clear all
NCT04308278 2024-10-30

EBVAST

Labo'Life

Phase 4 Recruiting
88 enrolled

Epstein-Barr Virus Infections

NCT04989491 2024-08-19

REPLY

University Hospital, Strasbourg, France

Phase 4 Recruiting
120 enrolled

Epstein-Barr Virus Infections

NCT05039580 2021-09-09

SEHC

The First Affiliated Hospital of Soochow University

Phase 4 Unknown
36 enrolled

Epstein-Barr Virus Infections

NCT04183738 2020-11-10

i2-D²EFT

Kirby Institute

Phase 4 Withdrawn

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Inflammation, Opportunistic Infections, Epstein-Barr Virus Infections, Coinfection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡